Results 71 to 80 of about 1,296 (184)
Several reports in the literature have described a differential sensitivity to ketolide antibiotics in ermB strains of Streptococcus pyogenes and Streptococcus pneumoniae resistant to erythromycin. Strains of S. pyogenes and S.
Zurawick, Kimberly +2 more
core +1 more source
The fourth International Conference on the Macrolides, Azalides, Streptogramins & Ketolides.
L. MINOLI +5 more
core
Chlamydia pneumoniae and Mycoplasma pneumoniae
Mycoplasma pneumoniae infection occurs worldwide and is the most common cause of community-acquired pneumonia (CAP) in 5- to 20-year-olds. The most reliable diagnostic test is the enzyme immunoassay, which allows immunoglobulin (Ig)G and IgM titration ...
L. Allegra +4 more
core +1 more source
A screening assay to test the inducing capacity of macrolides by fusing the attenuator of the inducible erm (B) gene from Streptococcus pneumoniae HM28 with the gfpmut1 gene has been
Gervais Clarebout, Roland Leclercq
core +1 more source
isolates each of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae were tested. The MIC at which 90 % of the isolates of both C. trachomatis and C.
Charles Parker +3 more
core
Ketolides are promising new antimicrobials effective against a broad range of Gram-positive pathogens, in part because of the low propensity of these drugs to trigger the expression of resistance genes.
DH Sherman (7940990) +7 more
core
Antibiotics targeting the bacterial ribosome typically bind to highly conserved rRNA regions with only minor phylogenetic sequence variations. It is unclear whether these sequence variations affect antibiotic susceptibility or resistance development.
Erik C. Böttger +13 more
core +1 more source
Understanding the background and clinical significance of the WHO, WOAH, and EMA classifications of antimicrobials to mitigate antimicrobial resistance. [PDF]
Gehring R, Mochel JP, Schmerold I.
europepmc +1 more source
Ketolides are promising new antimicrobials effective against a broad range of Gram-positive pathogens, due in part to the low propensity of these drugs to trigger the expression of resistance genes.
Mashal M. Almutairi (5638046)
core

